Issue
Alert me when new journal issues are available via or via
=free full text
Introduction: prostate cancer Susan F. Slovin page 561 Full Text | Full-Text PDF (36 KB)
The case for a biologically based classification of prostate cancer Christopher J Logothetis pages 562-566 Abstract | Full Text | Full-Text PDF (133 KB)
Predicting clinical end points: treatment nomograms in prostate cancer Christopher J Di Blasio, Audrey C Rhee, Daniel Cho, Peter T Scardino, Michael W Kattan pages 567-586 Abstract | Full Text | Full-Text PDF (370 KB)
Conservative versus radical therapy of prostate cancer: how have recent advances in molecular markers and imaging enhanced our ability to prognosticate risk? Scott Bagnall, Laurence Klotz pages 587-595 Abstract | Full Text | Full-Text PDF (145 KB)
Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer Steven A Leibel, Zvi Fuks, Michael J Zelefsky, Margie Hunt, Chandra M Burman, Gikas S Mageras, Chen-Shou Chui, Andrew Jackson, Howard I Amols, C.Clifton Ling pages 596-615 Abstract | Full Text | Full-Text PDF (311 KB)
Advances in imaging in the postoperative patient with a rising prostate-specific antigen level Hedvig Hricak, Heiko Schöder, Darko Pucar, Eric Lis, Steven C Eberhardt, Chinyere N Onyebuchi, Howard I Scher pages 616-634 Abstract | Full Text | Full-Text PDF (732 KB)
Genome-wide gene expression analysis of prostate carcinoma William L Gerald pages 635-648 Abstract | Full Text | Full-Text PDF (404 KB)
Immunotherapy for prostate cancer Lawrence Fong, Eric J Small pages 649-658 Abstract | Full Text | Full-Text PDF (157 KB)
DNA vaccines: an active immunization strategy for prostate cancer Jedd D Wolchok, Polly D Gregor, Luke T Nordquist, Susan F Slovin, Howard I Scher pages 659-666 Abstract | Full Text | Full-Text PDF (128 KB)
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen Neil H Bander, David M Nanus, Matthew I Milowsky, Lale Kostakoglu, Shankar Vallabahajosula, Stanley J Goldsmith pages 667-676 Abstract | Full Text | Full-Text PDF (489 KB)
Endothelin receptor antagonists in the treatment of prostate cancer Lance K Lassiter, Michael A Carducci pages 678-688 Abstract | Full Text | Full-Text PDF (116 KB)
The development of differentiation agents for the treatment of prostate cancer Matt Galsky, W.Kevin Kelly pages 689-697 Abstract | Full Text | Full-Text PDF (143 KB)
Differentiating agents and the treatment of prostate cancer: vitamin D3 and peroxisome proliferator-activated receptor gamma ligands Stacey B Leibowitz, Philip W Kantoff pages 698-708 Abstract | Full Text | Full-Text PDF (117 KB)
Hsp90 as a therapeutic target in prostate cancer David B Solit, Howard I Scher, Neal Rosen pages 709-716 Abstract | Full Text | Full-Text PDF (143 KB)
Role of bisphosphonates in prostate cancer bone metastases Theresa A Guise, John M Chirgwin pages 717-723 Abstract | Full Text | Full-Text PDF (151 KB)
October subject index pages 724-727 Full-Text PDF (38 KB)
Frontmatter
Masthead page A3 Full-Text PDF (40 KB)
Editorial board page A4 Full-Text PDF (36 KB)
TOC pages A7-A8 Full-Text PDF (34 KB)
Forthcoming issue page A9 Full-Text PDF (31 KB)
Future issues page A10 Full-Text PDF (23 KB)
Previous issues page A13 Full-Text PDF (31 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
